Placebo matching to spesolimab
1368-0140
Phase 3 small_molecule active
Quick answer
Placebo matching to spesolimab for Pyoderma gangrenosum is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Pyoderma gangrenosum
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active